THERAPEUTIC USES OF INHIBITORS OF RTP801

The present invention provides novel molecules, compositions, methods and uses for treating microvascular disorders, eye diseases and respiratory conditions based upon inhibition of the RTP801 gene and/or protein.

Saved in:
Bibliographic Details
Main Authors KAUFMANN, JÖRG, GIESE, KLAUS, FEINSTEIN, ELENA
Format Patent
LanguageEnglish
Polish
Published 31.01.2013
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention provides novel molecules, compositions, methods and uses for treating microvascular disorders, eye diseases and respiratory conditions based upon inhibition of the RTP801 gene and/or protein.
AbstractList The present invention provides novel molecules, compositions, methods and uses for treating microvascular disorders, eye diseases and respiratory conditions based upon inhibition of the RTP801 gene and/or protein.
Author FEINSTEIN, ELENA
KAUFMANN, JÖRG
GIESE, KLAUS
Author_xml – fullname: KAUFMANN, JÖRG
– fullname: GIESE, KLAUS
– fullname: FEINSTEIN, ELENA
BookMark eNrjYmDJy89L5WTQCPFwDXIMcA0N8XRWCA12DVbwd1Pw9PPwdPIM8Q8C84JCAiwMDHkYWNMSc4pTeaE0N4Oim2uIs4duakF-fGpxQWJyal5qSXyAj6G5paGpmUVIiLExMWoA750mMw
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate Terapeutyczne zastosowania inhibitorów RTP801
ExternalDocumentID PL1791568TT3
GroupedDBID EVB
ID FETCH-epo_espacenet_PL1791568TT33
IEDL.DBID EVB
IngestDate Fri Jul 19 13:58:07 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
Polish
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_PL1791568TT33
Notes Application Number: PL20050786796T
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20130131&DB=EPODOC&CC=PL&NR=1791568T3
ParticipantIDs epo_espacenet_PL1791568TT3
PublicationCentury 2000
PublicationDate 20130131
PublicationDateYYYYMMDD 2013-01-31
PublicationDate_xml – month: 01
  year: 2013
  text: 20130131
  day: 31
PublicationDecade 2010
PublicationYear 2013
RelatedCompanies Quark Pharmaceuticals, Inc
Silence Therapeutics Aktiengesellschaft
RelatedCompanies_xml – name: Silence Therapeutics Aktiengesellschaft
– name: Quark Pharmaceuticals, Inc
Score 2.874477
Snippet The present invention provides novel molecules, compositions, methods and uses for treating microvascular disorders, eye diseases and respiratory conditions...
SourceID epo
SourceType Open Access Repository
SubjectTerms BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
DERIVATIVES THEREOF
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
NUCLEIC ACIDS
NUCLEOSIDES
NUCLEOTIDES
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
SUGARS
VINEGAR
WINE
Title THERAPEUTIC USES OF INHIBITORS OF RTP801
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20130131&DB=EPODOC&locale=&CC=PL&NR=1791568T3
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ZS8NAEB5qFfVNq6L1IIIEX4Jpbh-CmItE2iSEjfSt7OaAgmiwEf--kyVRX_RtD5i9mG92Z-cAuFFMypihUqksaSFphUUli82oJFOlNGUDj5x1qoFFbIS59rTUlyNYD74wPE7oJw-OiBxVIL-3HK-bHyWWx20rN3dsjU1vDwGxPbF_HSMgzxBUPMf208RLXNF17XQuxpndReHUDYuoW7CNt2izs_7yn53OKaX5LVGCA9hJkdhrewij5mUCe-6QeG0Cu4v-vxuLPettjuCWhH72mPo5iVwhRxQUkkCI4jByIpJkvJaRFCXBMVwHPnFDCYdcfS9vlc6HyRFVPYExPvurUxBkyqqadcEzK0Wra5MW8j3VS6qikJarUjmD6d90pv91nsO-wpM6zBCBL2Dcvn9UlyhaW3bFN-ULyf16Zw
link.rule.ids 230,309,783,888,25578,76884
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ZS8NAEB5qFeubVqXWK4IUX4I5mjQ-BLE5SDRNQthI38JuDiiIFhvx7ztZEvVF3_aA2Yv5Znd251uAa2VGGdNVKhYFzcVpblDRYDIVJaoUM0nHJWeNa2AR6l46fVxqyx6sulgYzhP6yckRUaNy1Pea4_X6x4ll87eVm1u2wqK3e5eY9qQ9HSMgywgq9tx04siOrIllmXEwCROzYeHUdIOoW7CNO2yjodl3nudNUMr6t0Vx92EnRmGv9QH01i9DGFjdx2tD2F20992YbFVvcwg3xHOSh9hJiW8JKaKgELmCH3r-3CdRwnMJidESHMGV6xDLE7HJ7Ht4WRx0nSOqegx9PPaXIxAkysqKNeSZpTKtqhnNpTuqFVRFIy2VhXIC47_ljP-rvISBRxZBFvjh0ynsKfyDBxnR-Az69ftHeY5mtmYXfIK-AK87fVc
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=THERAPEUTIC+USES+OF+INHIBITORS+OF+RTP801&rft.inventor=KAUFMANN%2C+J%C3%96RG&rft.inventor=GIESE%2C+KLAUS&rft.inventor=FEINSTEIN%2C+ELENA&rft.date=2013-01-31&rft.externalDBID=T3&rft.externalDocID=PL1791568TT3